News

November 20, 2014November 20, 2014

OnCore and Baruch S. Blumberg Institute Partner Up to Cure Hepatitis B

Hepatitis B, News

OnCore Biopharma, Inc., a company focused on the development and commercialization of oral medication for the treatment of chronic hepatitis B virus (HBV) infection, has established a collaboration with the research ... Read more

November 19, 2014November 19, 2014

New Study Reveals Insights Into Hepatitis C Antiviral Resistance

Hepatitis C, News

A novel study on how miR-122 inhibition influences HCV replication, entitled “Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors,” was recently published in Nature Communications by Benjamin ... Read more

November 18, 2014November 18, 2014

Targeted Approach To Treating Hepatitis B Infection Could Lead to New Therapeutic Options

Hepatitis B, News

A new study entitled “Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in non transformed murine hepatocytes” shows that the hepatitis B ... Read more

November 17, 2014November 17, 2014

New Drug Regimen For Hepatitis C By Indiana University Produces 97 Percent Cure Rates

Hepatitis C, News

A recent study published in the New England Journal of Medicine describes the results of a new treatment regimen for hepatitis C that will transform the treatment protocols for transplant patients. The investigational three-drug ... Read more

November 14, 2014November 14, 2014

One In Ten Sausages in England & Wales Can Infect People With Hepatitis E If Under-Cooked

Hepatitis E, News

According to experts, one in every ten sausages and processed pork meat products on England and Wales carry risk of hepatitis E virus (HEV) infection if under-cooked. An abrupt rise has ... Read more

November 13, 2014November 14, 2014

Montefiore Medical Center Awarded With $3.5 Million Grant To Fight Hepatitis C

News

A $3.5 million grant was awarded to the Montefiore Medical Center to identify, diagnose and treat patients with hepatitis C (HCV). The grant is part of a $10 million Health Care Innovation Award ... Read more

November 13, 2014November 13, 2014

Phase 2 Study of Chronic Hepatitis C Treatment By Merck Shows Promise

Hepatitis C, News

Data from the C-WORTHY study evaluating the efficacy of treatment with Grazoprevir/Elbasvir of Chronic Hepatitis C in genotype 1 infected treatment-naïve and non-responders to peg-interferon/ribavirin (RP) patients was announced by ... Read more

November 12, 2014November 12, 2014

What Is the Real Cost of Treating All Patients with Hepatitis C And Can America Afford It?

Hepatitis C, News

Researchers from The University of Texas MD Anderson Cancer Center in Houston reported at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) their attempt to estimate ... Read more

November 10, 2014November 10, 2014

New York City Increases Hepatitis C Testing To Combat High Disease Incidences

Hepatitis C, News

Hepatitis C virus (HCV) is the leading cause of chronic liver disease and cirrhosis in the United States. According to the CDC, approximately 1.3% of the U.S. population is HCV ... Read more

November 10, 2014November 11, 2014

New Combination Therapy Works Well With Liver Transplants In Hepatitis C

Hepatitis C, News

During the American Association for the Study of Liver Diseases (The Liver Meeting® 2014) to be held in Boston, MA, between November 7 and 11, a new report will be ... Read more